Publications by authors named "Rosa Villatoro-Roldan"

Claim this Profile
T
The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy.
Ana Gómez Rueda, Álvaro Taus, Rosa Álvarez Álvarez, Reyes Bernabé-Caro, Luis Chara

Clin Transl Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming barriers to opioid-induced constipation management in cancer patients.
Esther Holgado Martín, Ana Blasco Cordellat, Marta Guix Arnau, Rosa Villatoro Roldán, Almudena Sanz Yagüe

Semin Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of COVID-19 in outpatients with cancer receiving active treatment in the context of a pandemic: An Andalusian cohort study.
Celia Martín-Bravo, Raúl Quirós, Isabel Blancas, Rosa Villatoro-Roldán, Marta Robles

Semin Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicentre observational study of the effectiveness, safety and economic impact of nivolumab on non-small-cell lung cancer in real clinical practice.
Macarena Merino Almazán, Juan Manuel Duarte Pérez, Juan Francisco Marín Pozo, Ana Laura Ortega Granados, Begoña Muros De Fuentes

Int J Clin Pharm· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nutritional risk and malnutrition rates at diagnosis of cancer in patients treated in outpatient settings: Early intervention protocol.
Elena Álvaro Sanz, Marga Garrido Siles, Laura Rey Fernández, Rosa Villatoro Roldán, Antonio Rueda Domínguez

Nutrition· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis